A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
Public ClinicalTrials.gov record NCT05814016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Infusion of Danavorexton in Participants With Moderate to Severe Obstructive Sleep Apnea Undergoing General Anesthesia for Abdominal Surgery
Study identification
- NCT ID
- NCT05814016
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- Danavorexton Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2023
- Primary completion
- Sep 24, 2024
- Completion
- Sep 24, 2024
- Last update posted
- Sep 15, 2025
2023 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Helen Keller Hospital | Sheffield | Alabama | 35660-6334 | — |
| Mayo Clinic - PPDS - Hospital | Phoenix | Arizona | 85054-4502 | — |
| UCSD | La Jolla | California | 92037-1300 | — |
| Cedars Sinai Medical Hospital | West Hollywood | California | 90048 | — |
| Mayo Clinic Jacksonville - PPDS | Jacksonville | Florida | 32224-1865 | — |
| University of Miami - Leonard M. Miller School of Medicine | Miami | Florida | 33136-1005 | — |
| Medical Research Center - Clinic/Outpatient Facility | Miami | Florida | 33165 | — |
| University of South Florida | Tampa | Florida | 33606-3601 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331-3609 | — |
| Rush University | Chicago | Illinois | 60622 | — |
| University of Louisville - Hospital | Louisville | Kentucky | 40202-3700 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02115-6110 | — |
| Inspira Health | Mullica Hill | New Jersey | 09061 | — |
| NYU Langone | Mineola | New York | 11501-3893 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794-0001 | — |
| Fairview Hospital | Cleveland | Ohio | 44111-5612 | — |
| Cleveland Clinic Hospital | Cleveland | Ohio | 44195-0001 | — |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210-1240 | — |
| The Medical College of Wisconsin, Inc. | Milwaukee | Wisconsin | 53226-3522 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05814016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05814016 live on ClinicalTrials.gov.